Fatal Hepatic Necrosis Due to Pyrimethamine-Sulfadoxine (Fansidar)
- 1 March 1987
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 106 (3) , 393-395
- https://doi.org/10.7326/0003-4819-106-3-393
Abstract
Pyrimethamine-sulfadoxine has been associated with severe and fatal cutaneous reactions as well as transient liver damage. We report the case of a patient who died of progressive hepatic failure caused by pyrimethamine-sulfadoxine administration. In addition, we summarize reports made to the Food and Drug Administration since 1982 that focus on hepatotoxic reactions to pyrimethamine-sulfadoxine. We suggest that fatal hepatic injury can occur after treatment with pyrimethamine-sulfadoxine and that physicians who prescribe the drug should be aware of this possibility.Keywords
This publication has 19 references indexed in Scilit:
- Severe Cutaneous Reactions among American Travelers Using Pyrimethamine-Sulfadoxine (Fansidar®) for Malaria ProphylaxisThe American Journal of Tropical Medicine and Hygiene, 1986
- ERYTHRODERMA WITH FULMINANT-HEPATITIS - A POSSIBLE ASSOCIATION1986
- Fulminant Hepatitis: Mayo Clinic Experience With 34 CasesMayo Clinic Proceedings, 1985
- Fansidar and Hepatic GranulomasAnnals of Internal Medicine, 1985
- ADVERSE REACTIONS TO PYRIMETHAMINE/SULFADOXINEThe Lancet, 1982
- PRESUMPTIVE FATALITY DUE TO PYRIMETHAMINE-SULFADOXINEThe Lancet, 1982
- SERIOUS REACTIONS DURING MALARIA PROPHYLAXIS WITH PYRIMETHAMINE-SULFADOXINEThe Lancet, 1982
- Hypersensitivity reaction to Sulfasalazine with Severe HepatotoxicityGastroenterology, 1978
- Diagnosis of Wilson's diseaseGastroenterology, 1978
- Exfoliative DermatitisArchives of Dermatology, 1973